Genetics of substance use disorders: a review (vol 51, pg 2189, 2021)

被引：0
|
作者：
Deak, Joseph D. [1 ,2 ]
Johnson, Emma C. [3 ]
机构：
[1] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA
[2] Vet Affairs Connecticut Healthcare Ctr, Dept Psychiat, West Haven, CT 06516 USA
[3] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
来源：
PSYCHOLOGICAL MEDICINE | 2022年 / 52卷 / 04期
关键词：
D O I：
10.1017/S0033291722000629
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：800 / 800
页数：1
相关论文
共 50 条
  • [1] Genetics of substance use disorders: a review
    Deak, Joseph D.
    Johnson, Emma C.
    PSYCHOLOGICAL MEDICINE, 2021, 51 (13) : 2189 - 2200
  • [2] Molecular genetics of substance use disorders: An umbrella review
    Lopez-Leon, Sandra
    Gonzalez-Giraldo, Yeimy
    Wegman-Ostrosky, Talia
    Forero, Diego A.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 124 : 358 - 369
  • [3] Genetics of Substance Use Disorders
    Yu, Cassie
    McClellan, Jon
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2016, 25 (03) : 377 - +
  • [4] An overview of the genetics of substance use disorders
    Lachman H.M.
    Current Psychiatry Reports, 2006, 8 (2) : 133 - 143
  • [5] Shared genetics of substance use disorders
    Kyle Vogan
    Nature Genetics, 2023, 55 : 727 - 727
  • [6] Genetics and pharmacogenetics of substance use disorders
    Tao, Pao-Luh
    Chen, Li-Shiun
    Chen, Chih-Ken
    Liu, Yu-Li
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2013, 21 : S23 - S24
  • [7] Shared genetics of substance use disorders
    Vogan, Kyle
    NATURE GENETICS, 2023, 55 (05) : 727 - 727
  • [8] 2021 at European Journal of Human Genetics: the year in review (vol 30, pg 3, 2021)
    McNeill, Alisdair
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (05) : 629 - 629
  • [9] PROGRESS IN THE GENETICS OF SUBSTANCE USE DISORDERS - AN UPDATE
    Agrawal, Arpana
    Edenberg, Howard
    Derks, Eske
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S10 - S10
  • [10] Genetics of pathological gambling and substance use disorders
    Comings, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S181 - S181
12345